APO Research
Talk to an analyst

APO RESEARCH · REPORT

Morning-after Pill

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Morning-after Pill Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchMorning-after Pill Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Morning-after Pill Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Morning-after Pill Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morning-after Pill Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Morning-after Pill Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Morning-after Pill market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Morning-after Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Morning-after Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Morning-after Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Morning-after Pill market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Morning-after Pill market include Zizhu Pharma, Zhejiang Xianju Pharma, Syzygy Healthcare, Regenex, Piramal, Mankind Pharma, Lupin, HRA Pharma and HLL Life Care, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Morning-after Pill market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Morning-after Pill and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Morning-after Pill sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Morning-after Pill market size, projected growth trends, production technologies, key applications, and end-use industries.

Morning-after Pill Segment by Company

Zizhu Pharma

Zhejiang Xianju Pharma

Syzygy Healthcare

Regenex

Piramal

Mankind Pharma

Lupin

HRA Pharma

HLL Life Care

Gedeon Richter

Foundation Consumer Healthcare

Morning-after Pill Segment by Type

Levonorgestrel

Ulipristal Acetate

Morning-after Pill Segment by Application

Online

Offline

Morning-after Pill Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Morning-after Pill status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Morning-after Pill market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Morning-after Pill significant trends, drivers, influence factors in global and regions.

6. To analyze Morning-after Pill competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morning-after Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morning-after Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morning-after Pill.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Morning-after Pill market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Morning-after Pill industry.

Chapter 3: Detailed analysis of Morning-after Pill manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Morning-after Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Morning-after Pill in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Morning-after Pill Industry Trends Table 2. Morning-after Pill Industry Drivers Table 3. Morning-after Pill Industry Opportunities and Challenges Table 4. Morning-after Pill Industry Restraints Table 5. Global Morning-after Pill Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Morning-after Pill Revenue Share by Company (2021-2026) Table 7. Global Morning-after Pill Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Morning-after Pill Sales Volume Share by Company (2021-2026) Table 9. Global Morning-after Pill Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Morning-after Pill Company Ranking, (2024-2026) & (USD Million) Table 11. Global Morning-after Pill Key Company Manufacturing Base & Headquarters Table 12. Global Morning-after Pill Company, Product Type & Application Table 13. Global Morning-after Pill Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Morning-after Pill by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Levonorgestrel Table 18. Significant Companies of Ulipristal Acetate Table 19. Global Morning-after Pill Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Morning-after Pill Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Morning-after Pill Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Morning-after Pill Sales Volume Share by Type (2021-2026) Table 23. Global Morning-after Pill Sales Volume Share by Type (2027-2032) Table 24. Global Morning-after Pill Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Morning-after Pill Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Morning-after Pill Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Morning-after Pill Sales Value Share by Type (2021-2026) Table 28. Global Morning-after Pill Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Online Table 30. Significant Companies of Offline Table 31. Global Morning-after Pill Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Morning-after Pill Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Morning-after Pill Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Morning-after Pill Sales Volume Share by Application (2021-2026) Table 35. Global Morning-after Pill Sales Volume Share by Application (2027-2032) Table 36. Global Morning-after Pill Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Morning-after Pill Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Morning-after Pill Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Morning-after Pill Sales Value Share by Application (2021-2026) Table 40. Global Morning-after Pill Sales Value Share by Application (2027-2032) Table 41. Global Morning-after Pill Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Morning-after Pill Sales by Region (2021-2026) & (K Units) Table 43. Global Morning-after Pill Sales Market Share by Region (2021-2026) Table 44. Global Morning-after Pill Sales by Region (2027-2032) & (K Units) Table 45. Global Morning-after Pill Sales Market Share by Region (2027-2032) Table 46. Global Morning-after Pill Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Morning-after Pill Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Morning-after Pill Sales Value Share by Region (2021-2026) Table 49. Global Morning-after Pill Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Morning-after Pill Sales Value Share by Region (2027-2032) Table 51. Global Morning-after Pill Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Morning-after Pill Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Morning-after Pill Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Morning-after Pill Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Morning-after Pill Sales by Country (2021-2026) & (K Units) Table 56. Global Morning-after Pill Sales Market Share by Country (2021-2026) Table 57. Global Morning-after Pill Sales by Country (2027-2032) & (K Units) Table 58. Global Morning-after Pill Sales Market Share by Country (2027-2032) Table 59. Global Morning-after Pill Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Morning-after Pill Sales Value Market Share by Country (2021-2026) Table 61. Global Morning-after Pill Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Morning-after Pill Sales Value Market Share by Country (2027-2032) Table 63. Zizhu Pharma Company Information Table 64. Zizhu Pharma Business Overview Table 65. Zizhu Pharma Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zizhu Pharma Morning-after Pill Product Portfolio Table 67. Zizhu Pharma Recent Development Table 68. Zhejiang Xianju Pharma Company Information Table 69. Zhejiang Xianju Pharma Business Overview Table 70. Zhejiang Xianju Pharma Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zhejiang Xianju Pharma Morning-after Pill Product Portfolio Table 72. Zhejiang Xianju Pharma Recent Development Table 73. Syzygy Healthcare Company Information Table 74. Syzygy Healthcare Business Overview Table 75. Syzygy Healthcare Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Syzygy Healthcare Morning-after Pill Product Portfolio Table 77. Syzygy Healthcare Recent Development Table 78. Regenex Company Information Table 79. Regenex Business Overview Table 80. Regenex Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Regenex Morning-after Pill Product Portfolio Table 82. Regenex Recent Development Table 83. Piramal Company Information Table 84. Piramal Business Overview Table 85. Piramal Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Piramal Morning-after Pill Product Portfolio Table 87. Piramal Recent Development Table 88. Mankind Pharma Company Information Table 89. Mankind Pharma Business Overview Table 90. Mankind Pharma Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mankind Pharma Morning-after Pill Product Portfolio Table 92. Mankind Pharma Recent Development Table 93. Lupin Company Information Table 94. Lupin Business Overview Table 95. Lupin Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lupin Morning-after Pill Product Portfolio Table 97. Lupin Recent Development Table 98. HRA Pharma Company Information Table 99. HRA Pharma Business Overview Table 100. HRA Pharma Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. HRA Pharma Morning-after Pill Product Portfolio Table 102. HRA Pharma Recent Development Table 103. HLL Life Care Company Information Table 104. HLL Life Care Business Overview Table 105. HLL Life Care Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. HLL Life Care Morning-after Pill Product Portfolio Table 107. HLL Life Care Recent Development Table 108. Gedeon Richter Company Information Table 109. Gedeon Richter Business Overview Table 110. Gedeon Richter Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Gedeon Richter Morning-after Pill Product Portfolio Table 112. Gedeon Richter Recent Development Table 113. Foundation Consumer Healthcare Company Information Table 114. Foundation Consumer Healthcare Business Overview Table 115. Foundation Consumer Healthcare Morning-after Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Foundation Consumer Healthcare Morning-after Pill Product Portfolio Table 117. Foundation Consumer Healthcare Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Morning-after Pill Distributors List Table 121. Morning-after Pill Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Morning-after Pill Product Image Figure 2. Global Morning-after Pill Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Morning-after Pill Sales Value (2021-2032) & (US$ Million) Figure 4. Global Morning-after Pill Sales (2021-2032) & (K Units) Figure 5. Global Morning-after Pill Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Morning-after Pill Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Levonorgestrel Image Figure 10. Ulipristal Acetate Image Figure 11. Global Morning-after Pill Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Morning-after Pill Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Morning-after Pill Sales Volume Share by Type (2021-2032) Figure 14. Global Morning-after Pill Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Morning-after Pill Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Morning-after Pill Sales Value Share by Type (2021-2032) Figure 17. Online Image Figure 18. Offline Image Figure 19. Global Morning-after Pill Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Morning-after Pill Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Morning-after Pill Sales Volume Share by Application (2021-2032) Figure 22. Global Morning-after Pill Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Morning-after Pill Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Morning-after Pill Sales Value Share by Application (2021-2032) Figure 25. Global Morning-after Pill Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Morning-after Pill Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Morning-after Pill Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Morning-after Pill Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Morning-after Pill Sales Value (2021-2032) & (US$ Million) Figure 30. North America Morning-after Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Morning-after Pill Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Morning-after Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Morning-after Pill Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Morning-after Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Morning-after Pill Sales Value (2021-2032) & (US$ Million) Figure 36. South America Morning-after Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Morning-after Pill Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Morning-after Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Morning-after Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Morning-after Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Morning-after Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Morning-after Pill Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Morning-after Pill Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Levonorgestrel
  • Ulipristal Acetate
Applications
  • Online
  • Offline
Companies covered
  • Zizhu Pharma
  • Zhejiang Xianju Pharma
  • Syzygy Healthcare
  • Regenex
  • Piramal
  • Mankind Pharma
  • Lupin
  • HRA Pharma
  • HLL Life Care
  • Gedeon Richter
  • Foundation Consumer Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Morning-after Pill Sales Value (2021-2032)
  4. 1.2.2 Global Morning-after Pill Sales Volume (2021-2032)
  5. 1.2.3 Global Morning-after Pill Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Morning-after Pill Market Dynamics
  1. 2.1 Morning-after Pill Industry Trends
  2. 2.2 Morning-after Pill Industry Drivers
  3. 2.3 Morning-after Pill Industry Opportunities and Challenges
  4. 2.4 Morning-after Pill Industry Restraints
3 Morning-after Pill Market by Company
  1. 3.1 Global Morning-after Pill Company Revenue Ranking in 2025
  2. 3.2 Global Morning-after Pill Revenue by Company (2021-2026)
  3. 3.3 Global Morning-after Pill Sales Volume by Company (2021-2026)
  4. 3.4 Global Morning-after Pill Average Price by Company (2021-2026)
  5. 3.5 Global Morning-after Pill Company Ranking (2024-2026)
  6. 3.6 Global Morning-after Pill Company Manufacturing Base and Headquarters
  7. 3.7 Global Morning-after Pill Company Product Type and Application
  8. 3.8 Global Morning-after Pill Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Morning-after Pill Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Morning-after Pill Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Morning-after Pill Market by Type
  1. 4.1 Morning-after Pill Type Introduction
  2. 4.1.1 Levonorgestrel
  3. 4.1.2 Ulipristal Acetate
  4. 4.2 Global Morning-after Pill Sales Volume by Type
  5. 4.2.1 Global Morning-after Pill Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Morning-after Pill Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Morning-after Pill Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Morning-after Pill Sales Value by Type
  9. 4.3.1 Global Morning-after Pill Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Morning-after Pill Sales Value by Type (2021-2032)
  11. 4.3.3 Global Morning-after Pill Sales Value Share by Type (2021-2032)
5 Morning-after Pill Market by Application
  1. 5.1 Morning-after Pill Application Introduction
  2. 5.1.1 Online
  3. 5.1.2 Offline
  4. 5.2 Global Morning-after Pill Sales Volume by Application
  5. 5.2.1 Global Morning-after Pill Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Morning-after Pill Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Morning-after Pill Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Morning-after Pill Sales Value by Application
  9. 5.3.1 Global Morning-after Pill Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Morning-after Pill Sales Value by Application (2021-2032)
  11. 5.3.3 Global Morning-after Pill Sales Value Share by Application (2021-2032)
6 Morning-after Pill Regional Sales and Value Analysis
  1. 6.1 Global Morning-after Pill Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Morning-after Pill Sales by Region (2021-2032)
  3. 6.2.1 Global Morning-after Pill Sales by Region: 2021-2026
  4. 6.2.2 Global Morning-after Pill Sales by Region (2027-2032)
  5. 6.3 Global Morning-after Pill Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Morning-after Pill Sales Value by Region (2021-2032)
  7. 6.4.1 Global Morning-after Pill Sales Value by Region: 2021-2026
  8. 6.4.2 Global Morning-after Pill Sales Value by Region (2027-2032)
  9. 6.5 Global Morning-after Pill Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Morning-after Pill Sales Value (2021-2032)
  12. 6.6.2 North America Morning-after Pill Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Morning-after Pill Sales Value (2021-2032)
  15. 6.7.2 Europe Morning-after Pill Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Morning-after Pill Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Morning-after Pill Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Morning-after Pill Sales Value (2021-2032)
  21. 6.9.2 South America Morning-after Pill Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Morning-after Pill Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Morning-after Pill Sales Value Share by Country, 2025 VS 2032
7 Morning-after Pill Country-level Sales and Value Analysis
  1. 7.1 Global Morning-after Pill Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Morning-after Pill Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Morning-after Pill Sales by Country (2021-2032)
  4. 7.3.1 Global Morning-after Pill Sales by Country (2021-2026)
  5. 7.3.2 Global Morning-after Pill Sales by Country (2027-2032)
  6. 7.4 Global Morning-after Pill Sales Value by Country (2021-2032)
  7. 7.4.1 Global Morning-after Pill Sales Value by Country (2021-2026)
  8. 7.4.2 Global Morning-after Pill Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Morning-after Pill Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Morning-after Pill Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Morning-after Pill Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Morning-after Pill Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Morning-after Pill Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Morning-after Pill Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Morning-after Pill Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Morning-after Pill Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Morning-after Pill Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Morning-after Pill Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Morning-after Pill Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Morning-after Pill Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Morning-after Pill Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Morning-after Pill Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Morning-after Pill Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Morning-after Pill Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Morning-after Pill Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Morning-after Pill Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Morning-after Pill Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Morning-after Pill Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Morning-after Pill Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Morning-after Pill Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Morning-after Pill Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Morning-after Pill Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Morning-after Pill Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Morning-after Pill Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Morning-after Pill Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Morning-after Pill Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Morning-after Pill Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Morning-after Pill Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Morning-after Pill Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zizhu Pharma
  2. 8.1.1 Zizhu Pharma Company Information
  3. 8.1.2 Zizhu Pharma Business Overview
  4. 8.1.3 Zizhu Pharma Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zizhu Pharma Morning-after Pill Product Portfolio
  6. 8.1.5 Zizhu Pharma Recent Developments
  7. 8.2 Zhejiang Xianju Pharma
  8. 8.2.1 Zhejiang Xianju Pharma Company Information
  9. 8.2.2 Zhejiang Xianju Pharma Business Overview
  10. 8.2.3 Zhejiang Xianju Pharma Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Xianju Pharma Morning-after Pill Product Portfolio
  12. 8.2.5 Zhejiang Xianju Pharma Recent Developments
  13. 8.3 Syzygy Healthcare
  14. 8.3.1 Syzygy Healthcare Company Information
  15. 8.3.2 Syzygy Healthcare Business Overview
  16. 8.3.3 Syzygy Healthcare Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Syzygy Healthcare Morning-after Pill Product Portfolio
  18. 8.3.5 Syzygy Healthcare Recent Developments
  19. 8.4 Regenex
  20. 8.4.1 Regenex Company Information
  21. 8.4.2 Regenex Business Overview
  22. 8.4.3 Regenex Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Regenex Morning-after Pill Product Portfolio
  24. 8.4.5 Regenex Recent Developments
  25. 8.5 Piramal
  26. 8.5.1 Piramal Company Information
  27. 8.5.2 Piramal Business Overview
  28. 8.5.3 Piramal Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Piramal Morning-after Pill Product Portfolio
  30. 8.5.5 Piramal Recent Developments
  31. 8.6 Mankind Pharma
  32. 8.6.1 Mankind Pharma Company Information
  33. 8.6.2 Mankind Pharma Business Overview
  34. 8.6.3 Mankind Pharma Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mankind Pharma Morning-after Pill Product Portfolio
  36. 8.6.5 Mankind Pharma Recent Developments
  37. 8.7 Lupin
  38. 8.7.1 Lupin Company Information
  39. 8.7.2 Lupin Business Overview
  40. 8.7.3 Lupin Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lupin Morning-after Pill Product Portfolio
  42. 8.7.5 Lupin Recent Developments
  43. 8.8 HRA Pharma
  44. 8.8.1 HRA Pharma Company Information
  45. 8.8.2 HRA Pharma Business Overview
  46. 8.8.3 HRA Pharma Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 HRA Pharma Morning-after Pill Product Portfolio
  48. 8.8.5 HRA Pharma Recent Developments
  49. 8.9 HLL Life Care
  50. 8.9.1 HLL Life Care Company Information
  51. 8.9.2 HLL Life Care Business Overview
  52. 8.9.3 HLL Life Care Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 HLL Life Care Morning-after Pill Product Portfolio
  54. 8.9.5 HLL Life Care Recent Developments
  55. 8.10 Gedeon Richter
  56. 8.10.1 Gedeon Richter Company Information
  57. 8.10.2 Gedeon Richter Business Overview
  58. 8.10.3 Gedeon Richter Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Gedeon Richter Morning-after Pill Product Portfolio
  60. 8.10.5 Gedeon Richter Recent Developments
  61. 8.11 Foundation Consumer Healthcare
  62. 8.11.1 Foundation Consumer Healthcare Company Information
  63. 8.11.2 Foundation Consumer Healthcare Business Overview
  64. 8.11.3 Foundation Consumer Healthcare Morning-after Pill Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Foundation Consumer Healthcare Morning-after Pill Product Portfolio
  66. 8.11.5 Foundation Consumer Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Morning-after Pill Value Chain Analysis
  2. 9.1.1 Morning-after Pill Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Morning-after Pill Sales Mode & Process
  6. 9.2 Morning-after Pill Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Morning-after Pill Distributors
  9. 9.2.3 Morning-after Pill Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst